El dolor articular profundo requiere potencia sin sobrecarga térmica

High-energy penetration, wavelength-selective absorption, pulse thermal control

An older dog can walk into a veterinary rehabilitation room looking fine and still refuse to climb three steps. The owner usually describes the same frustrating pattern: the dog gets up slowly, walks better for a few minutes, then starts shortening the stride again. Oral medication may reduce pain, but the clinician still has to manage gastrointestinal, renal, hepatic, sedation, or long-term medication concerns. Conventional cold laser may be comfortable, but a thick-coated, large-breed dog with a deep hip or stifle problem creates another problem: how much useful optical energy actually reaches the painful tissue?

That is where high-intensity Class IV laser therapy becomes a clinical engineering problem rather than a simple “laser versus no laser” decision.

For laser therapy for dogs, the practical question is not whether more power is automatically better. It is whether sufficient energy can reach the target tissue while controlling surface temperature, exposure time, wavelength absorption, and cumulative dose. FotonMedix’s veterinary platform, for example, combines multiple wavelengths, high peak power, super-pulse operation, adjustable thermal sensation, and depth-maintaining technology in a system designed for veterinary rehabilitation. The VetMedix-Max is specified with 650, 810, 915, 940, and 980 nm wavelengths and up to 38 W peak power. (FotonMedix |)

The distinction matters most when the target is not the skin.

The Real Problem With Treating a Large Dog’s Arthritic Joint

Consider a 34 kg Labrador with chronic stifle osteoarthritis.

The clinician can place the treatment head directly over the joint. The problem is that the tissue between the handpiece and the arthritic structure is not optically transparent. Skin, subcutaneous fat, fascia, muscle, blood, and connective tissue all interact with the photons.

Some photons are scattered.

Some are absorbed.

Some continue deeper.

The amount reaching the joint therefore decreases with depth, and it does not decrease in exactly the same way for every wavelength.

This is why a treatment protocol based only on “watts” can be misleading.

A 20 W setting does not mean that 20 W is arriving at the joint surface. Nor does a 1,000 J treatment mean that 1,000 J has been deposited into the pathological structure. The actual biological dose depends on spot size, tissue optical properties, contact technique, movement speed, wavelength, pulse structure, exposure duration, and the anatomical depth of the target.

A 2025 review in Optics and Lasers in Engineering emphasized that penetration depth and dosimetry are central variables in photobiomodulation because the delivered surface dose is not equivalent to the dose reaching the target tissue. (科学直通车)

For veterinary clinicians, this becomes especially obvious in large dogs.

A small terrier with a relatively superficial elbow target and a heavy Labrador with a deep hip target should not automatically receive the same treatment strategy.

Why Surface Heating Can Fool the Operator

High-intensity laser therapy creates a useful amount of thermal energy when optical absorption occurs.

The danger is not simply “heat.”

The real issue is where the heat is generated and how quickly it is removed.

If too much energy is absorbed near the skin while the pathological structure remains under-dosed, the dog may become uncomfortable before the clinician achieves a meaningful deep-tissue effect.

This creates the classic clinical contradiction:

More power improves energy delivery, but excessive instantaneous energy deposition can increase unwanted superficial heating.

The solution is not necessarily to reduce the treatment intensity until the system becomes physiologically insignificant.

The more useful approach is to manage wavelength selection, scanning technique, exposure duration, pulse frequency, duty cycle, and thermal feedback together.

Why Tissue Depth Changes the Laser Strategy

The optical behavior of biological tissue is governed by absorption and scattering.

Shorter wavelengths generally experience stronger scattering, while absorption depends heavily on chromophores such as hemoglobin, water, melanin, and other tissue constituents. A review of tissue optical properties explains that scattering decreases as wavelength increases, while absorption changes according to the absorbing components present in the tissue. (PubMed Central (PMC))

This means that the “best wavelength” does not exist independently of the clinical target.

For a dog with superficial inflammation, one strategy may be reasonable.

For a dog with a deep arthritic hip, the clinician may need a different balance.

For post-operative tissue, another wavelength combination may be more appropriate.

This is one reason multi-wavelength veterinary platforms are commercially interesting for B2B clinics. VetMedix-Max combines five wavelengths and provides a high-power super-pulse mode intended to support deeper treatment while allowing the operator to manage thermal sensation. (FotonMedix |)

The point is not to use five wavelengths simply because five wavelengths are available.

The point is to match optical behavior to tissue depth and treatment objective.

980 nm Changes the Thermal Equation

The 980 nm region deserves special attention in high-intensity treatment.

At 980 nm, water absorption is higher than around the commonly used 800 nm penetration window, although it is still far below the strong water absorption associated with approximately 1470 nm. Experimental work on high-energy photobiomodulation has shown that 980 nm can generate localized heating through absorption by tissue water. (PubMed Central (PMC))

This can be clinically useful.

It can also become a problem if the clinician treats power as the only control variable.

A 980 nm beam does not simply “go deep.” It interacts with tissue on the way in. Blood and water contribute to optical absorption, while scattering redistributes the light.

Published optical studies also demonstrate why the absorption behavior of 980 and 1470 nm should not be treated as interchangeable. In vascular laser literature, 1470 nm has substantially stronger absorption in water-containing tissue than 980 nm, producing a much shorter effective optical penetration depth. (J-STAGE)

For a veterinary rehabilitation application, that distinction is valuable.

The clinician can think of 980 nm as a wavelength with a meaningful balance between deeper delivery and thermal interaction, while 1470 nm is much more strongly dominated by water absorption and is therefore associated with a much more localized photothermal effect.

That is why the 1470 nm and 980 nm channels found in FotonMedix’s SurgMedix-Max are positioned differently from its high-energy veterinary rehabilitation system. SurgMedix-Max specifies 1470 nm at 20 W and 980 nm at 40 W alongside a 635 nm channel, with applications centered on surgical tissue interaction such as coagulation, evaporation, cutting, and incision. (FotonMedix |)

A veterinary rehabilitation clinician should not simply transfer surgical 1470 nm parameters into a non-invasive arthritis protocol.

The wavelength physics can inform treatment planning, but the clinical objective is different.

What About Hemoglobin at 980 nm?

The relationship between 980 nm and hemoglobin is more complicated than saying that 980 nm is “a hemoglobin wavelength.”

Hemoglobin absorption is strongly wavelength-dependent, and tissue contains both oxyhemoglobin and deoxyhemoglobin. The absorption spectrum also changes with oxygenation state. (PubMed Central (PMC))

At 980 nm, water absorption becomes increasingly relevant, while hemoglobin still contributes to optical absorption.

For high-intensity veterinary treatment, this matters because blood flow is part of the thermal system.

A vascularized muscle region can absorb energy and then redistribute heat through perfusion. If tissue circulation increases, heat removal can also increase. At the same time, excessive localized absorption can raise temperature faster than perfusion can remove it.

That is why “more blood flow” should never be treated as a universal excuse for increasing power.

The useful clinical goal is controlled energy deposition.

Why 1470 nm Is Different

1470 nm is a very different tool.

Water absorption rises dramatically in this region. Published data comparing near-infrared wavelengths show that water absorption at 1470 nm is many times higher than at 980 nm, which produces much more localized energy deposition. (J-STAGE)

This property is highly useful in laser surgery, where controlled tissue vaporization or coagulation is required.

It is not automatically a reason to use 1470 nm for routine non-invasive canine arthritis treatment.

This distinction is important for medical distributors and veterinary clinics evaluating a high-intensity laser platform.

One machine can contain multiple wavelength channels, but that does not mean every channel should be used at maximum output for every indication.

A good veterinary system should give the clinician control over the treatment strategy rather than forcing one wavelength and one power profile onto every patient.

Duty Cycle Is the Safety Valve Between Power and Heat

The most practical concept in high-intensity laser therapy is often not maximum power.

It is average energy delivery over time.

Suppose a clinician uses a high peak output but does not deliver that output continuously. During the “on” period, tissue receives a strong optical stimulus. During the “off” period, thermal diffusion and blood perfusion have time to redistribute energy.

This is where duty cycle becomes clinically relevant.

A 50% duty cycle means the laser is active for approximately half of the pulse cycle. A lower duty cycle reduces average power while maintaining a higher instantaneous peak during the active portion.

The distinction is important because peak power and average power describe different physical behaviors.

Recent experimental work on dual-wavelength laser-tissue interaction has also investigated pulsed operation using a 100 ms pulse, 50% duty cycle, and 5 Hz frequency, demonstrating that pulse structure is an important parameter when controlling laser-tissue effects. (Life Science Network)

For veterinary rehabilitation, the practical lesson is straightforward:

If the target requires strong energy delivery but the surface begins to become uncomfortable, changing the temporal structure may be more useful than simply abandoning high-intensity treatment.

The handpiece should also remain in controlled motion rather than sitting over one small point for too long.

A Simulated Canine Arthritis Case From a Veterinary Rehabilitation Department

The following case is a simulated clinical training case, created to demonstrate how a veterinary rehabilitation team could reason through wavelength selection, power, pulse structure, energy, and treatment progression. It is not presented as a published patient record and should not be treated as a universal treatment prescription.

Case Identification

The patient is a 9-year-old male neutered Labrador Retriever weighing 34.2 kg.

Radiographic evaluation shows bilateral stifle osteoarthritis, with the right side clinically dominant.

The right stifle is graded as moderate-to-severe degenerative joint disease, corresponding approximately to a modified radiographic grade 3 of 4 used within the training protocol.

The dog has difficulty rising after rest, reduced willingness to climb stairs, shortened right hind-limb stride, and discomfort during extension.

The owner reports that conventional analgesic management improves comfort but does not restore normal activity.

The rehabilitation objective is not to “erase arthritis.”

The objective is to reduce pain-related movement restriction, improve functional activity, and support a broader multimodal rehabilitation program.

Simulated Clinical Case Table

ParameterSimulated Case DetailDepartmentVeterinary Rehabilitation and Physical MedicineCase NumberVR-HILT-2026-027PatientLabrador RetrieverAge9 yearsSexMale, neuteredBody Weight34.2 kgPrimary DiagnosisCanine stifle osteoarthritisClinical GradeModerate-to-severe, modified radiographic Grade 3/4Dominant SideRight stifleBaseline Functional IssueSlow rising, stair avoidance, shortened stridePrimary Treatment ObjectivePain modulation and functional mobility supportLaser PlatformHigh-intensity veterinary Class IV laserPrimary Wavelength Strategy810 nm + 915 nm + 940 nm + 980 nmSimulated Wavelength Allocation810 nm 30%, 915 nm 25%, 940 nm 20%, 980 nm 25%Peak PowerUp to 30 W during pulsed deliveryInitial Average PowerApproximately 12 WPulse Frequency10 HzInitial Duty Cycle40%Initial Session Energy720 JTreatment AreaRight stifle and surrounding periarticular soft tissueTreatment Frequency2 sessions per week initiallyPlanned Initial Course3 weeksReassessmentEnd of Week 1, Week 3, Week 6Thermal MonitoringContinuous patient response and surface temperature observationAdditional RehabilitationControlled exercise and range-of-motion work

The wavelength allocation above is a simulated protocol model, not a manufacturer-prescribed treatment setting.

The reason for including 810 nm is to maintain a relatively favorable near-infrared penetration profile. A review of PBM optical behavior identifies the region around 800 nm as being close to a favorable penetration window because scattering is comparatively reduced. (PubMed Central (PMC))

The 915 and 940 nm components broaden the optical interaction across the treatment volume, while the 980 nm component adds a stronger thermal interaction that must be controlled by movement, exposure time, pulse structure, and patient feedback.

Sesión 1

The dog initially resists full stifle extension.

The operator begins with a lower average output rather than immediately using maximum available power.

The handpiece is maintained in contact or near-contact with the treatment area and moved continuously across the periarticular tissues.

The total delivered energy is 720 J.

The dog shows mild warmth but no withdrawal response.

The clinician records:

Stifle extension tolerance improved immediately after treatment

No visible erythema

No signs of excessive discomfort

Gait remains mildly shortened

Owner reports no immediate adverse response

The important observation is not that the dog suddenly becomes “cured.”

It is that the treatment can be delivered at a clinically meaningful energy level without creating unacceptable surface heating.

End of Week 1

After two sessions, the simulated owner-reported pain interference score falls from 7/10 to 5/10.

The dog begins standing more quickly after lying down.

The right hind limb is still visibly weaker, but the dog voluntarily walks farther before slowing.

The treatment energy is increased to approximately 850 J per session, while the clinician keeps the duty cycle below continuous output.

The purpose of the adjustment is not simply to increase total joules.

It is to increase the useful dose while maintaining thermal tolerance.

Semana 2

The dog receives two further sessions.

The clinician changes the treatment pattern slightly.

The central stifle region receives shorter exposure periods, while the surrounding quadriceps, hamstring, periarticular, and soft-tissue regions receive broader scanning.

This is a critical practical detail.

An arthritic joint is not just a piece of cartilage.

Pain-related movement changes can create secondary muscle tension and altered loading patterns. Treating only the anatomical center of the joint can therefore miss part of the functional problem.

The simulated treatment energy is maintained around 850–900 J per session.

Week 3 Reassessment

At the end of six treatment sessions, the simulated functional results are:

Clinical MeasureBaselineWeek 1Week 3Pain interference score7/105/103/10Rising from restMarkedly slowModerate difficultyMild difficultyStair toleranceAvoids stairs3–4 steps8–10 stepsRight hind-limb strideClearly shortenedMildly shortenedNear-symmetrical at slow walkingPassive extension tolerancePoorImprovedClearly improvedOwner-rated daily activity4/106/108/10Simulated treatment energy/session720 J850 J900 J

These values are deliberately presented as simulated training data.

They should not be interpreted as expected outcomes for every dog.

Why the Treatment Was Not Simply Set to Maximum Power

This is where high-intensity treatment differs from a “turn it up” approach.

VetMedix-Max is specified for up to 38 W peak power and provides super-pulse operation, adjustable thermal sensation, and multiple wavelengths. (FotonMedix |)

A 38 W peak capability does not mean that every canine joint should receive 38 W continuously.

The clinical system needs headroom.

The operator can use higher peak output during short pulse intervals while reducing the average thermal burden through duty-cycle control and scanning.

This creates a more useful relationship between intensity and treatment comfort.

The objective becomes:

strong optical stimulation without allowing superficial temperature to become the limiting factor.

What the Published Canine Evidence Actually Shows

It is important not to overstate the veterinary evidence.

A 2022 randomized double-blinded controlled trial evaluated Class IV photobiomodulation in 20 dogs and 40 joints with osteoarthritis. The treatment group received Class IV laser therapy over three weeks. The investigators reported better outcomes in several pain, function, gait, and osteoarthritis-related measures at selected follow-up points, particularly at days 8, 15, and 30. (PubMed)

That is useful evidence, but it does not mean every dog will respond identically.

Another study involving 23 dogs with naturally occurring osteoarthritis used six consecutive weekly laser treatments and objective accelerometer monitoring. Daily activity and step counts increased from baseline during the treatment period, and systemic analgesics were reduced in 50% of the dogs during the study. (PubMed Central (PMC))

A separate retrospective study of 17 dogs reported reductions in pain scores after laser treatment and found that analgesic therapy was reduced by the clinician at week 2 in 13 dogs. No laser-related side effects were observed in that cohort. (PubMed)

The evidence therefore supports laser therapy as a potentially useful component of multimodal canine osteoarthritis management.

It does not justify claiming that laser therapy replaces medication, surgery, weight management, exercise therapy, or orthopedic intervention.

Where Dog Laser Therapy Fits in a Real Clinic

A practical dog laser therapy workflow is usually more valuable when the clinician thinks in terms of functional rehabilitation rather than isolated energy delivery.

For example, a dog with hip osteoarthritis may receive:

Orthopedic assessment

Pain scoring

Weight and activity review

Tratamiento con láser

Passive range-of-motion work

Controlled walking

Ejercicios de fortalecimiento

Reassessment of gait and owner-reported function

The laser becomes one component of a broader rehabilitation plan.

This matters because pain reduction can create an opportunity for movement.

Movement can then support muscle preservation.

Muscle preservation can reduce abnormal joint loading.

The result is a more useful clinical chain than simply recording the number of joules delivered.

Why Laser Therapy for Dogs Arthritis Should Be Treated as a Dosimetry Problem

The search phrase laser therapy for dogs arthritis sounds simple.

The clinical reality is not.

Arthritis can involve cartilage degeneration, synovial inflammation, capsular thickening, osteophyte formation, periarticular muscle changes, altered gait, and chronic pain sensitization.

These tissues do not have identical optical properties.

A superficial synovial or periarticular target may respond differently from a deep joint structure surrounded by thick muscle.

That is why a fixed “one protocol for all dogs” approach is difficult to defend scientifically.

The clinician needs to consider:

Tissue Depth

A deep hip joint requires more attention to photon attenuation and treatment geometry than a superficial digital joint.

Longitud de onda

Longer wavelengths generally scatter less, but absorption can increase sharply depending on the wavelength and tissue chromophore.

Potencia

Higher peak power can improve treatment efficiency but also increases the need for thermal management.

Frecuencia de impulsos

Pulse frequency affects how energy is distributed over time and can be used with duty cycle to modify average exposure.

Ciclo de trabajo

Lowering duty cycle can reduce average thermal load while preserving higher instantaneous output.

Contact Technique

Poor contact or inconsistent handpiece movement changes the delivered optical dose and makes treatment reproducibility worse.

Energía total

Joules matter, but total joules without treatment area, time, power profile, and wavelength information are incomplete.

This is why professional laser protocols should record more than “900 J delivered.”

A B2B View of the Veterinary Laser Investment

For a veterinary hospital or rehabilitation center, the business question is also practical.

A machine dedicated to one narrow indication can be difficult to justify.

A multi-wavelength veterinary platform can support orthopedic rehabilitation, pain management, inflammation control, wound management, and selected surgical applications depending on configuration and local regulatory scope.

FotonMedix positions VetMedix-Max as a medical-grade veterinary platform combining laser therapy and laser surgery, with five wavelengths, 38 W peak power, super-pulse operation, thermal adjustment, and a stated 15 cm tissue penetration capability. (FotonMedix |)

The broader FotonMedix LaserMedix platform also emphasizes five-wavelength treatment, high-energy PBM, depth-maintaining technology, dual hot-and-cold functionality, and temperature indication. (FotonMedix |)

For a distributor, this creates a clearer sales proposition than simply saying “high-power laser.”

The conversation can move toward clinical workflow:

Can the same platform support chronic pain cases?

Can it support canine arthritis rehabilitation?

Can clinicians adjust treatment depth and thermal sensation?

Can the veterinary team establish repeatable protocols?

Can the system be integrated into rehabilitation rather than used as an isolated procedure?

Those are questions a clinic manager can actually answer.

The Difference Owners Notice Is Usually Not the Laser

The owner does not care whether the machine delivered 720 J or 900 J.

They care whether the dog gets up without struggling.

They care whether the dog wants to walk to the door.

They care whether stairs become possible again.

They care whether the dog can sleep comfortably.

That is the real endpoint.

Published canine osteoarthritis research has increasingly used functional outcomes rather than relying only on imaging. In the 23-dog accelerometer study, objective activity measurements increased during the treatment course, showing why mobility can be a more meaningful real-world endpoint than simply describing an X-ray. (PubMed Central (PMC))

Radiographic arthritis may remain.

The osteophytes may remain.

The degenerative changes may remain.

But if pain is better controlled and the dog moves more normally, the rehabilitation outcome can still be clinically meaningful.

Laser Versus Traditional Care Is Not Really an Either-Or Decision

It is tempting to frame laser treatment against medication as if one must replace the other.

Clinical practice is more complicated.

NSAIDs can be highly effective for canine osteoarthritis, but long-term pharmacological management requires appropriate veterinary assessment and monitoring.

Exercise therapy addresses strength and function.

Weight management reduces mechanical loading.

Joint injections may be appropriate for selected cases.

Surgery can be necessary when structural disease is severe.

Laser therapy offers another non-invasive modality that can be incorporated into this broader plan.

A 2026 evidence review concluded that the available evidence for adding laser therapy to NSAID treatment remains limited and described the strength of evidence as weak, while still suggesting possible improvements in pain and lameness. (PubMed)

That is exactly the kind of statement that should appear in serious B2B medical marketing.

The product should be sold on controllable technology and clinical utility, not on exaggerated promises.

Practical Takeaway for Veterinary Teams

For a large dog with deep joint pain, the hardest part is not producing more laser energy.

The hard part is delivering enough useful energy to the target while keeping the superficial tissues comfortable.

That requires an understanding of optical attenuation, wavelength-dependent absorption, treatment geometry, power, pulse frequency, duty cycle, exposure time, and tissue temperature.

980 nm can create meaningful thermal interaction because tissue water absorbs part of the energy.

1470 nm interacts with water much more strongly and is therefore far more localized and thermally intense, making it particularly relevant to surgical tissue applications rather than automatically suitable for non-invasive arthritis protocols. (PubMed Central (PMC))

Near the 800 nm region, tissue scattering is comparatively favorable for penetration, which helps explain why multi-wavelength systems can be useful when treatment depth varies between anatomical targets. (PubMed Central (PMC))

Pulse structure then gives the clinician another control layer.

Instead of treating peak power as the whole story, the clinician can manage average exposure and thermal accumulation through duty cycle, frequency, handpiece movement, and treatment duration.

That is the real advantage of modern high-intensity Class IV systems.

Not simply more power.

More controllable power.

For laser therapy for dogs, that difference becomes particularly important when the target is deep, the patient is large, and the treatment needs to be repeated over several weeks.

For dog laser therapy, the most useful platform is not necessarily the machine with the biggest number on the specification sheet. It is the system that allows the veterinary team to adjust wavelength, intensity, pulse behavior, treatment time, and thermal response according to the patient.

And for laser therapy for dogs arthritis, the clinical goal should remain grounded in the dog’s actual life: less pain during movement, better functional activity, improved tolerance of rehabilitation, and a treatment process that can be integrated with the rest of veterinary care.

That is where high-intensity laser therapy can earn its place beside conventional treatment rather than being marketed as a replacement for it.